Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia
- PMID: 38419903
- PMCID: PMC10899493
- DOI: 10.3389/fpsyt.2024.1358578
Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia
Abstract
Bipolar disorder and schizophrenia are serious psychiatric conditions that cause a significant reduction in quality of life and shortened life expectancy. Treatments including medications and psychosocial support exist, but many people with these disorders still struggle to participate in society and some are resistant to current therapies. Although the exact pathophysiology of bipolar disorder and schizophrenia remains unclear, increasing evidence supports the role of oxidative stress and redox dysregulation as underlying mechanisms. Oxidative stress is an imbalance between the production of reactive oxygen species generated by metabolic processes and antioxidant systems that can cause damage to lipids, proteins, and DNA. Sleep is a critical regulator of metabolic homeostasis and oxidative stress. Disruption of sleep and circadian rhythms contribute to the onset and progression of bipolar disorder and schizophrenia and these disorders often coexist with sleep disorders. Furthermore, sleep deprivation has been associated with increased oxidative stress and worsening mood symptoms. Dysfunctional brain metabolism can be improved by fatty acid derived ketones as the brain readily uses both ketones and glucose as fuel. Ketones have been helpful in many neurological disorders including epilepsy and Alzheimer's disease. Recent clinical trials using the ketogenic diet suggest positive improvement in symptoms for bipolar disorder and schizophrenia as well. The improvement in psychiatric symptoms from the ketogenic diet is thought to be linked, in part, to restoration of mitochondrial function. These findings encourage further randomized controlled clinical trials, as well as biochemical and mechanistic investigation into the role of metabolism and sleep in psychiatric disorders. This narrative review seeks to clarify the intricate relationship between brain metabolism, sleep, and psychiatric disorders. The review will delve into the initial promising effects of the ketogenic diet on mood stability, examining evidence from both human and animal models of bipolar disorder and schizophrenia. The article concludes with a summary of the current state of affairs and encouragement for future research focused on the role of metabolism and sleep in mood disorders.
Keywords: bipolar disorder; ketogenic diet; metabolism; schizophrenia; sleep.
Copyright © 2024 Choi, Kang, Kim and Nehs.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Similar articles
-
The Potential Effects of the Ketogenic Diet in the Prevention and Co-Treatment of Stress, Anxiety, Depression, Schizophrenia, and Bipolar Disorder: From the Basic Research to the Clinical Practice.Nutrients. 2024 May 21;16(11):1546. doi: 10.3390/nu16111546. Nutrients. 2024. PMID: 38892480 Free PMC article. Review.
-
The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol.Front Nutr. 2024 Aug 21;11:1444483. doi: 10.3389/fnut.2024.1444483. eCollection 2024. Front Nutr. 2024. PMID: 39234289 Free PMC article.
-
Ketogenic-Mimicking Diet as a Therapeutic Modality for Bipolar Disorder: Biomechanistic Rationale and Protocol for a Pilot Clinical Trial.Nutrients. 2023 Jul 7;15(13):3068. doi: 10.3390/nu15133068. Nutrients. 2023. PMID: 37447394 Free PMC article.
-
The Role of Ketogenic Metabolic Therapy on the Brain in Serious Mental Illness: A Review.J Psychiatr Brain Sci. 2022;7(5):e220009. doi: 10.20900/jpbs.20220009. Epub 2022 Oct 31. J Psychiatr Brain Sci. 2022. PMID: 36483840 Free PMC article.
-
Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments.Neurosci Biobehav Rev. 2018 Nov;94:11-16. doi: 10.1016/j.neubiorev.2018.07.020. Epub 2018 Jul 31. Neurosci Biobehav Rev. 2018. PMID: 30075165 Review.
Cited by
-
Methylation levels in the GRIN2B promoter region are associated with bipolar disorder and its anxiety and insomnia symptoms.Exp Ther Med. 2025 May 23;30(1):144. doi: 10.3892/etm.2025.12894. eCollection 2025 Jul. Exp Ther Med. 2025. PMID: 40496762 Free PMC article.
-
The Potential Effects of the Ketogenic Diet in the Prevention and Co-Treatment of Stress, Anxiety, Depression, Schizophrenia, and Bipolar Disorder: From the Basic Research to the Clinical Practice.Nutrients. 2024 May 21;16(11):1546. doi: 10.3390/nu16111546. Nutrients. 2024. PMID: 38892480 Free PMC article. Review.
-
Retrospective case study: ketogenic metabolic therapy in the effective management of treatment-resistant depressive symptoms in bipolar disorder.Front Nutr. 2024 Aug 12;11:1394679. doi: 10.3389/fnut.2024.1394679. eCollection 2024. Front Nutr. 2024. PMID: 39188977 Free PMC article.
-
Mediational effect analysis of childhood emotional abuse on prodromal psychotic symptoms in self-taught examination students.Sci Rep. 2025 Jun 6;15(1):19932. doi: 10.1038/s41598-025-05062-5. Sci Rep. 2025. PMID: 40481152 Free PMC article.
-
Unraveling the interplay between sleep, redox metabolism, and aging: implications for brain health and longevity.Front Aging. 2025 May 21;6:1605070. doi: 10.3389/fragi.2025.1605070. eCollection 2025. Front Aging. 2025. PMID: 40469623 Free PMC article. Review.
References
-
- Jimenez-Fernandez S, Gurpegui M, Garrote-Rojas D, Gutierrez-Rojas L, Carretero MD, Correll CU. Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls. Bipolar Disord (2021) 23(2):117–29. doi: 10.1111/bdi.12980 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources